Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Commure

Health Tech & Medtech · San Francisco, United States · Founded 2017 Unicorn

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$5–10B
Latest valuation · 2026
Unlock exact value
Revenue
$100–500M
Latest reported FY
Unlock exact value
Headcount
1–2k
Current team size
Unlock exact value

Developer of an FHIR standard-based platform focused on accelerating healthcare software innovation

Investors

7 investors on Commure's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 1 investor entered at this stage
Series B+ 6 investors entered at this stage

Global footprint

Where Commure has talent and traffic

AI talent share
0.4% of workforce is AI talent
(7 of 1,560 staff)
Core AI20.13%
Other AI50.32%
Non-AI workforce1,55399.55%
Workforce by country
12 countries with
team presence
🇺🇸 United States53.3%
🇮🇳 India35.8%
🇧🇩 Bangladesh7.3%
🇨🇴 Colombia1.6%
🇧🇷 Brazil0.9%
Top 5 of 12 shown
Web traffic by country
150K monthly visits
across markets
🇺🇸 United States86.1%
🇧🇩 Bangladesh4.8%
🇮🇳 India2.7%
🇳🇱 Netherlands1.1%
🇬🇧 United Kingdom0.9%
Top 5 markets shown

Patent intelligence

$914k patent portfolio · 6 active families

Estimated portfolio value
$914k
0.02% of valuation · 1.5× the top peer athenahealth ($595k)
6 active patent families
Where Commure innovates Medical treatmentData miningFamily medicineMedical careMedical emergency

Where Commure concentrates vs peers

Each axis is a top-10 topic across Commure and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

Commure's 7 investments and acquisitions.

Every disclosed deal where Commure appeared as a backer or acquirer, 2017–2024. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

7 deals across Commure's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        01 · Deployment strategy vs peers

        Where Commure deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        02 · Portfolio market map

        Commure's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        7 of 7 deals

        Sentiment on X

        What X is saying about Commure

        An AI-synthesized read of the highest-engagement posts about Commure on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Commure on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.